The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
Authors:
Open Access
- 17 March 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 14, 1134105
Abstract
Introduction: Bile acid diarrhoea (BAD) is a common disorder that results from an increased loss of primary bile acids and can result in a change in microbiome. The aims of this study were to characterise the microbiome in different cohorts of patients with BAD and to determine if treatment with a bile acid sequestrant, colesevelam, can alter the microbiome and improve microbial diversity.Materials and methods: Patients with symptoms of diarrhoea underwent 75-selenium homocholic acid (75SeHCAT) testing and were categorised into four cohorts: idiopathic BAD, post-cholecystectomy BAD, post-operative Crohn’s disease BAD and 75SeHCAT negative control group. Patients with a positive 75SeHCAT (p < 0.05. Colesevelam did not alter bacterial α/β-diversity but patients who clinically responded to treatment had a significantly greater abundance of Fusobacteria and Ruminococcus, both of which aid in the conversion of primary to secondary bile acids.Conclusion: This is the first study to examine treatment effects on the microbiome in BAD, which demonstrated a possible association with colesevelam on the microbiome through bile acid modulation in clinical responders. Larger studies are now needed to establish a causal relationship with colesevelam and the inter-crosstalk between bile acids and the microbiome.Keywords
Funding Information
- Bowel and Cancer Research
- Tillotts Pharma
This publication has 48 references indexed in Scilit:
- Bile acid transporters and regulatory nuclear receptors in the liver and beyondJournal of Hepatology, 2013
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- Managing bile acid diarrhoeaTherapeutic Advances in Gastroenterology, 2010
- Bile acid malabsoption: a forgotten diagnosis?Clinical Medicine, 2010
- Recent advances in the understanding of bile acid malabsorptionBritish Medical Bulletin, 2009
- Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: A retrospective chart review and patient questionnaireClinical Therapeutics, 2009
- Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiomeProceedings of the National Academy of Sciences, 2008
- Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasisCell Metabolism, 2005
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences of the United States of America, 2003
- Primary Bile Acid Malabsorption: A Pathophysiologic and Clinical Entity?Scandinavian Journal of Gastroenterology, 1992